Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Senators contend the life saving drug is too high for many patients. Senators grilled Novo Nordisk CEO Lars Jorgensen ...
Novo Nordisk charges $969 per month for Ozempic in the U.S., compared to $155 per month in Canada and $59 in Germany.
The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback